Level Eight Ventures
Level Eight Ventures, founded in 2018 and based in Ann Arbor, Michigan, is a venture capital firm that focuses on investing in innovative companies operating in sectors such as artificial intelligence, clean energy, mobility, healthcare, materials, chemicals, sensors, inspection, resources, and the environment. Recognizing the rapid advancements in biochemistry, materials science, robotics, and artificial intelligence, the firm aims to support outstanding teams that are creating cleaner, smarter, and more sustainable solutions. By providing both time and capital, Level Eight Ventures seeks to drive disruption and foster the development of technologies that will enhance various industries across North America and Europe.
SpinTech MRI
Series A in 2022
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.
Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.
Invision AI
Seed Round in 2017
Invision AI specializes in developing advanced artificial intelligence software that enhances the functionality of edge devices within the Internet of Things (IoT). The company's innovative platform leverages proprietary machine learning algorithms to analyze video data, enabling devices to generate valuable situational insights without the need for costly hardware or reliance on cloud storage. By utilizing existing visual data and millions of images, Invision AI's technology reduces bandwidth costs associated with traditional motion detection systems, thereby significantly improving the user experience. The firm aims to redefine the capabilities of video monitoring technologies through its cloud-based video analytics solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.